News & Articles

New research assesses the interaction between the SARS-CoV-2 Spike S1 protein receptor binding domain (SARS-CoV-2 S1 RBD) and heparin

Roche will access SpeeDx existing tests and technology to expand diagnostic products for the management of antibiotic resistance in STIs

These four viral infections have similar patient presentations, making accurate detection and differentiation critical during next flu season

The RECOVERY trial has shown that the cheap and widely available steroid cut deaths by one-third among patients critically ill with COVID-19

The test detects antibodies made by the immune system in response to infection by the novel coronavirus in as little as 10 minutes

Companies team-up to promote the use of protein footprinting technologies, products, and contract research services in biopharmaceutical research and development

It's comprehensive SARS-COV-2 offerings span RT-PCR, high throughput RNA extraction, automation, ELISA and lateral flow based serology testing.

Join this expert webinar to discover the complexities and challenges for wide patient access to new chimeric antigen receptor T (CAR-T) cell therapies

Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide

R&D expert Dr. Francisco Ylera shares the secret to fast and flexible formatting of antibodies to accelerate your research

This aims to assist labs involved with the essential RT-PCR assay part of the “test, trace and isolate” strategy

Discover on demand an antibody discovery campaign targeting a cell surface receptor implicated in cancer

Highly specific prototype test detects the virus spike protein at clinically relevant concentrations

Don't miss this webinar to find out how researchers at LifeArc are using ALK-specific antibodies as a mechanism of directly targeting ALK-expressing neuroblastoma cells

Our expert webinar series aims to help you get the most from your drug discovery research

Total antibody test aims to deliver superior clinical performance with 100% sensitivity and 99.8% specificity

Join us on Tuesday, June 9, to explore the qualitative and quantitative characterization of mAb and protein stability, both in vitro and in vivo, by CE-MS and LC-MS

Automated “lateral flow” dispensing technology is vital step in rapid point-of-care antibody test production

Company to make the device available through broad range of healthcare, state, employer and consumer-initiated channels